-
Will Right to Try Increase Access to Experimental Treatments?
The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients.
by Marci A. Landsmann
-
What Older Patients Value
Many older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.
by Cheryl Platzman Weinstock
-
Omitting Obesity
Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.
by Cici Zhang
-
Questioning an Entrenched Practice
To defend against bacterial infections, cancer patients are often put on a neutropenic diet—which bars fresh fruits and vegetables, among other things. Research indicates that following this diet is unnecessary.
by Brad Jones
-
Cancer Patients Who Are Parents
Patients who are diagnosed with advanced cancer while parenting young children have special priorities and needs.
by Cheryl Platzman Weinstock
-
Advocacy Spotlight: Sorting Out Priorities
Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
Bill Aims to Improve Childhood Cancer Research
The STAR Act passes in the U.S. House of Representatives.
by Brad Jones
-
Measuring Your Movement
Researchers are exploring whether wearable personal activity monitors could provide doctors with a more complete picture of cancer patients' well-being.
by Brad Jones
-
Talking About Medical Marijuana
Medical oncologists discuss marijuana with their patients. Many of these doctors feel they aren't well enough informed to make recommendations about it, but some do anyway.
by Kate Yandell
-
Men Less Likely to Get Genetic Testing
A study suggests women are more likely than men to undergo genetic testing for mutations linked to hereditary cancer.
by Cheryl Platzman Weinstock
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles